Directory
>
Kristine Chavez
Kristine Chavez
COO
Los Altos, California, United States
Kristine Chavez
Summary
Kristine Chavez is a seasoned executive with extensive experience in the biopharmaceutical industry, currently serving as COO of Innomab Inc. She co-founded the company and has played a pivotal role in evaluating numerous project opportunities, focusing on in-licensing and partnerships. With a robust background in project management at Cambridge Antibody Technology, she oversaw a range of programs from development to commercialization. Her earlier roles include Project Director at Genencor, where she was involved in vaccine development, and significant positions at Inhale and Syntex/Roche, where she honed her expertise in CMC development and operations. Kristine holds a B.A. in Biological Sciences from the University of California, Berkeley, showcasing her strong academic foundation in biology. Her specialties encompass business development, alliance management, and regulatory affairs, positioning her as a leader in her field.
Kristine Chavez
Work Experience
COO at
INNOMAB PTE. LTD.
Present
VP, Project Management at
Cambridge Antibody Technology
October 2005 - November 2007
Dir. Project Management at
Genencor
February 2003 - November 2005
Dir., Project Management at
Inhale
January 2000 - January 2002
Kristine Chavez
Education
Frequently Asked Questions about Kristine Chavez
What is Kristine Chavez email address?
Kristine Chavez's primary email address is *******@kitepharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
Where Kristine Chavez graduated from?
Kristine Chavez holds a degree in Biology from University of California, Berkeley.
How can I directly contact Kristine Chavez?
To contact Kristine Chavez directly, you can use the email address *******@kitepharma.com. Complete contact information is available upon registration with Muraena.
Who is Kristine Chavez?
Kristine Chavez is a seasoned executive with extensive experience in the biopharmaceutical industry, currently serving as COO of Innomab Inc. She co-founded the company and has played a pivotal role in evaluating numerous project opportunities, focusing on in-licensing and partnerships. With a robust background in project management at Cambridge Antibody Technology, she oversaw a range of programs from development to commercialization. Her earlier roles include Project Director at Genencor, where she was involved in vaccine development, and significant positions at Inhale and Syntex/Roche, where she honed her expertise in CMC development and operations. Kristine holds a B.A. in Biological Sciences from the University of California, Berkeley, showcasing her strong academic foundation in biology. Her specialties encompass business development, alliance management, and regulatory affairs, positioning her as a leader in her field.
Kristine`s contact details
*******@kitepharma.com